Last reviewed · How we verify
Edema due to Nephrotic Syndrome
Approved treatments
- Spironolacton · ACS Biomarker
- Diuril · Salix Pharms
- Microzide · Generic (originally Merck)
Lisinopril inhibits ACE, reducing angiotensin II and aldosterone, leading to lower blood pressure. - Aldactone · Generic (originally Searle/Pfizer)
Potassium-sparing diuretic and mineralocorticoid receptor antagonist that blocks aldosterone, reducing fluid retention and lowering blood pressure. - spirolactone · Second Xiangya Hospital of Central South University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Edema due to Nephrotic Syndrome patent landscape — cliff calendar, originator estates, attackable patents
- Edema due to Nephrotic Syndrome treatment landscape brief
- Edema due to Nephrotic Syndrome treatment updates RSS
Frequently asked questions about Edema due to Nephrotic Syndrome
What drugs treat Edema due to Nephrotic Syndrome?
Tracked treatments include Spironolacton, Diuril, Microzide, Aldactone, spirolactone.
What is the treatment for Edema due to Nephrotic Syndrome?
Standard treatment for Edema due to Nephrotic Syndrome includes Spironolacton, Diuril, Microzide, Aldactone, spirolactone. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Edema due to Nephrotic Syndrome patent cliff · Edema due to Nephrotic Syndrome CI report
- Treatment: Spironolacton · ACS Biomarker
- Treatment: Diuril · Salix Pharms
- Treatment: Microzide · Generic (originally Merck)
- Treatment: Aldactone · Generic (originally Searle/Pfizer)
- Treatment: spirolactone · Second Xiangya Hospital of Central South University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing